The COVID-19 pandemic is one of the greatest public health emergencies of our time. The development of new diagnostics, treatments and vaccinations has arguably required greater innovation and collaboration across research, pharmaceutical industry and healthcare sectors than ever before. This event reflects on innovations and collaborations during the COVID-19 pandemic. Consideration will be given to applying what has been learnt to future pandemics.

Aim
To reflect on innovations and collaborations in pharmaceutical science that have made an impact against COVID-19. To consider how to apply this learning to our response to future pandemics.

Learning objectives:

• Explain how pharmaceutical scientists innovated and collaborated in the fight against COVID-19.
• List challenges and opportunities for the development of diagnostics, treatments and vaccinations during the COVID-19 pandemic;
• Discuss approaches for fast-tracking diagnostics, treatments and vaccinations in future pandemics without compromising patient safety.
• Reflect on what has been learned from innovative and collaborative approaches during the COVID-19 pandemic that can be used for future pandemics.

Moderator:
- Chris John, FIP Lead for Data and Intelligence, UK

Panellists:
- Louise Druedahl, Researcher University of Copenhagen, Denmark
- N Udupa, Research Director Shri Dharmasthala Manjunatheshwara University, India
- Yvonne Perrie, Professor of Drug Delivery University of Strathclyde, UK

Long covid, also known as post COVID-19 condition, is estimated to affect 10-20% of people who develop COVID-19. While the majority go on to fully recover, this group of people suffer a variety of physical, physiological and cognitive symptoms for many weeks, months and sometimes longer. The condition can be debilitating and recovery requires a holistic and personalised care approach, including pharmaceutical care.

This event by FIP aims to explore in more depth what long covid is, what the key characteristics and symptoms are and how these symptoms can be managed in the pharmacy. The panellists include a public health expert on long-covid-19, a clinical pharmacist who is recovering from long covid, a physiotherapist and more.

Learning objectives:
1. Describe the key characteristics and symptoms of long COVID-19
2. Understand the latest research and evidence concerning treatment and care
3. Discuss ways long covid symptoms can be managed in the pharmacy
4. Identify the importance of pharmacists' understanding of the condition and care needs

Moderator:
- Leonila Ocampo, FIP Community Pharmacy Section, Asia Pacific Institute for Medication Management Philippine Pharmacists Association, Philippines

Panellists:
- Darren Brown, Clinical Academic Physiotherapist, Chelsea and Westminster Hospital NHS Foundation Trust; Long COVID Physio, United Kingdom
- Rani Khatib, Consultant Cardiology Pharmacist and Associate Professor University of Leeds, United Kingdom
- Lucette Cysique, Associate Professor The University of New South Wales, Australia

This event will showcase how nations have coordinated pharmacy support for person-centred care in the fight against COVID-19 with a focus on strategy, policy and practice. Barriers and enablers to pharmacy’s involvement in the pandemic will be discussed as well as insights for countries wanting to advocate for pharmacy’s greater contribution in health systems. The future role of pharmacy in pandemics will be highlighted.

Aim
To describe current and future pharmacy practice in delivering person-centred care during the fight against COVID-19 and possible future pandemics.

Learning objectives:

1. List policy and professional enablers and barriers for developing pharmacy practice during the COVID-19 pandemic;
2. Give examples of pharmacy services used in the fight against COVID-19;
3. Describe approaches for advocating for pharmacy support in pandemics;
4. Predict the role of the pharmacist and their teams in future pandemics.

Moderators:
-Nadia Bukari, FIP Global Lead/Associate Professor, University College London FIP/UCL, UK
-Abby Kahaleh, PhD, MS, BPharm, MPH, FAACP, FIP Global Lead on Quality Assurance for Pharmacy Education, Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty, Roosevelt University, USA

Panelsits:
-Suzete Costa, PharmD, MPH, PhD Executive Director & Senior Research Director Institute for Evidence-Based Health (ISBE), Portugal
-Michael Ganio, Senior Director, Pharmacy Practice and Quality ASHP, USA
-Shepard Mhlaba, FIP Global Lead, FIP Workforce Development Hub, WDG2: Early career training strategy, Drug Information Pharmacist/Research Assistant, Drug and Toxicology Information Services (DATIS), Harare, Zimbabwe

This event is to update pharmacy professionals about managing workforce demand in a pandemic – now and in future. Case studies will be presented from countries across the globe. These will address how we ensure continuity of workforce supply during this and future pandemics, how can we reduce demand on the workforce and the role of healthcare regulators play.

Aim
To present to attendees approaches for managing workforce demand in a pandemic.

Learning objectives
1. Discuss how continuity of workforce supply can be managed during pandemics
2. Discuss how demand for the pharmaceutical workforce can be reduced during pandemics
3. Describe the impact of COVID-19 pandemic on the pharmacy workforce
4. Explain how pharmacists can be prepared for the role of vaccinator.

Moderator:
- Christopher John, FIP Lead for Data and Intelligence, FIP, UK

Panelists:
- Mariet Eksteen, Global Lead for FIP Development Goal 7: Advancing Integrated Services; Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa
- Chima Amadi, Global Lead, FIP Development Goal 13 (Workforce Policy Formation); Education and Training Personnel Pharmacists’ Council Nigeria, Nigeria
- Rula Darwish, Exco committee FIP academic section WDG9 Lead; Professor School of Pharmacy/ The University of Jordan, CPD Chair in JPA,  Jordan
- Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services; Lecturer University of Bremen, Germany

With the COVID-19 pandemic, effective use of educational technologies has become essential. Many different aspects of technology have been introduced or further expanded, including remote experiential learning or simulations for virtual patient care. At the same time, artificial intelligence enabled faculties to accelerate and advance research and clinical care in the pharmaceutical sciences and clinical pharmacy practice.

Introduction and implementation of any technology-enabled education and training includes many success factors such as technology literacy amongst educators and students. To enhance technology-enabled pharmaceutical education, this digital event will outline good practices and engage participants in identifying a SWOT (Strengths, Weaknesses, Opportunities, and Threats) of technology and AI use in education.

At the end of this session, participants will: 
1.Learn about current and future good practices about the educational technologies used in higher/pharmaceutical education
2.Contribute to the development of a SWOT in using Technology & AI in pharmaceutical education
3.Identify ways to enhance quality of education and academic capacity by utilizing technology and AI in pharmaceutical education

Co-chairs:
- Lilian Azzopardi, Dean Department of Pharmacy, University of Malta, Malta
- Jaime Acosta Gómez, FIP Community Pharmacy Section, FIP Technology Forum co-chair, FIP COVID19 Expert Advisory Group member; Community Pharmacist and pharmacy owner Farmacia Acosta, Spain

Panelists:
-Mia Sivén, Vice-Dean University of Helsinki, Finland
-Francesca Wirth, Senior Lecturer University of Malta, Malta
-Daniel Malone, Pharmacy Course Director Monash University, Australia

Facilitator:
-Aysu Selcuk, FIP AIM Advisory Committee Member, FIP Education and Primary Health Care Policies Specialist, Turkey

This event is to update pharmacy professionals about the range of therapeutic options currently available for COVID-19. It will take an evidence-based approach and also look at future development of therapeutic agents.

Aim
To update attendees on the latest therapeutic advances against COVID-19

Learning objectives
1. Explain which medicines are available that target the virus or provide symptom control
2. Discuss which medicines will be effective against new variants.
3. Describe what other medicines are available and what is the evidence for them.
4. List medicines in the pipeline for treating COVID-19

Moderator:
-Christopher John, FIP Lead for Data and Intelligence, FIP - UK

Panelists:
-Syed Shahzad Hasan, Senior Research Fellow University of Huddersfield-UK
-Trevor Jones, Visiting Professor King’s College London - UK

Around the world, community pharmacies play an increasingly consolidated role in vaccination. During the pandemic, pharmacies’ accessibility made them a convenient place for vaccination against COVID-19 in several countries, increasing vaccination coverage and helping achieve herd immunity. As the world slowly begins to emerge from the pandemic, this event will discuss the role of community pharmacies in COVID-19 booster vaccination, and their challenges in vaccine supply logistics and cold storage solutions, particularly in a post-pandemic scenario. Key interventions by community pharmacists in vaccine supply logistics linked to COVID-19 from different parts of the world will be presented.

Learning objectives:

1. Understand the supply chain and distribution process of COVID-19 vaccines from manufacturer to hospitals, community pharmacies, and the public;

2. Explore the role of community pharmacies in vaccine supply logistics for COVID-19;

3. Discuss the challenges of COVID-19 booster vaccination supply logistics and cold storage solutions in community pharmacies, particularly in a post-pandemic scenario;

4. Explore supply models that involve community pharmacies contributing to population vaccination coverage in a post-pandemic scenario.

Moderator:
- Catherine Duggan, Chief Executive Officer FIP, the Netherlands

Panellists:
- Vibhu Paudyal, Associate Professor in Clinical Pharmacy University of Birmingham, UK
- Ronald T. Piervincenzi, Ph.D., Chief Executive Officer USP, USA
- Loganathan Fahrni, Senior lecturer and pharmacist Universiti Teknologi MARA, Malaysia

The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.

Learning objectives:

1. To identify the current role of the pharmacist in tetanus, diphtheria, acellular pertussis booster, COVID vaccination, and meningococcal meningitis vaccination.
2. To explore needs, drivers, and barriers for expanding that role in countries that have regulated pharmacy-based vaccination services.
3. To give examples from countries with pharmacy-based vaccination services  in advocating a broader role for pharmacists in vaccination

Moderators:

- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education, University College London, United Kingdom

- Manjiri Gharat, FIP Vice-President, India 

Panellists:

- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, French Chamber of Pharmacists, France

- Zhi Shan Sujata, Pharmacist, Malaysian Pharmacists Society, Malaysia

-  Sham Moodley, Pharmacist,  Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc, South Africa

- Zeid Kilani, President, Jordan Pharmacists Association, Jordan

- Mas Rahman Roestan, Operational Director of PT Biofarma and Expert Council of Indonesian Pharmacists Association, Indonesian Pharmacists Association, Indonesia

- Irma Beatriz Caponi, Farmacéutica, COFA, Argentina

Facilitators & Speakers:

- Christopher John, FIP Lead for Data and Intelligence, UK 

- Zheng Kang Lum, PhD candidate, National University of Singapore, Singapore

- Allie Jo Shipman, Director, State Policy, National Alliance of State Pharmacy Associations, USA

- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia

This is the COVID-19 programme initiator and will set the scene: why this programme; main outcomes; FIP advocacy role. It aligns with 800 days since pandemic and will launch SustainabilityRx website/ Visualisation (FIP’s response to COVID-19) with a focus on pandemic preparedness.


Learning objectives
1. Describe the functionality of the SustainabilityRx website
2. Outline the current COVID-19 situation from the perspectives of practice, science and workforce/education;
3. Consider steps that can be taken to prepare for future pandemics.

Moderators:
- Christopher John, FIP Lead for Data and Intelligence, FIP, UK
- Dr Lina Bader/Dr Sherly Meilianti FIP Lead for Workforce Transformation/FIP Data and Intelligence Specialist, FIP-Saudi Arabia

Panelists:
- Dr Hoai-An Truong, Professor and Director of Public Health, School of Pharmacy & Health Professions, University of Maryland Eastern Shore, USA
- Dr John Grabenstein, Member of FIP COVID-19 Expert Advisory Group, President Vaccine Dynamics SP, USA
- Prof. Trevor Jones, Visiting Professor King’s College London, UK
- Dr Ally Dering-Anderson, Current member of the FIP COVID-19 Expert Advisory Groupm, Clinical Associate Professor in the Department of Pharmacy Practice & Science University of Nebraska College of Pharmacy, USA
- Shaun Gleason, FIP Hub DG1 Lead, Member of the COVID-19 Expert Advisory Group, Assistant Dean for Distance Degrees and Programs; Associate Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus, USA

Despite all good intentions, all humans carry unconscious biases. How do these impact our ability to provide culturally appropriate care to our patients? This interactive session is meant to target all pharmacists and educators in practice to promote understanding on the influence of unconscious bias on health disparities, like COVID-19. Specifically, experts will share the neuroscience of how implicit bias, strategies to disrupt bias, and address how bias can influence our patient care interactions.

At the end of this session, participants will be able to:
1. Define implicit bias and its impact on health disparities.
2. Discuss the impact of unconscious bias and how it affects our relationships with patients, students, and colleagues.
3. Identify and reflect on own biases.
4. List strategies to mitigate unconscious bias in pharmacy practice to improve patient-centred care.

Moderator:
- Mohamed Amin, Associate Professor, Beirut Arab University, Lebanon

Facilitator:
- Dalia Bajis, FIP lead for Provision and Partnerships, FIP, Bahrain

Panellist: 
- Sally Arif, Associate Professor of Pharmacy Practice/ Clinical Pharmacist, Midwestern University College of Pharmacy/ Rush University Medical Center, USA

Covid-19 complications include a wide spectrum of clinical manifestations. COVID-19 -associated invasive mould infections have been identified as a serious global health problem. These invasive infections present differently and vary in their risk factors. Pharmacists can play a vital role in raising awareness, prevention, and treatment of these emerging pathogens. In addition, pharmacists’ role is vital to providing care to patients suffering from Long Covid. Long Covid conditions are a wide range of new, returning, or ongoing health problems people can experience for four or more weeks after contracting SARS-CoV-2. These complications can occur in individuals with serious, mild, or no symptoms during the SARS-CoV-2 infection. However, the burden is not well understood and treatment approaches need further study.

This webinar will raise awareness of the pharmacist's role in supporting patients with COVID-19 associated mould infections and Long Covid.

Learning objectives:
1. Recognize manifestations and risk factors of Long Covid.
2. Provide actionable steps to care for people with post-covid conditions -as part of multi-disciplinary teams.
3. Describe common manifestations and risk factors of COVID-19-associated mould infections.
4. Identify prevention measures for COVID-19 associated mold infections.
5. Recognize treatments for COVID-19-associated mould infections.

Moderator:
- John Hertig, VP Americas (PAHO), Assoc. Prof. and Vice-Chair of Pharmacy Practice, Butler University, USA

Panelists:
-Dallas James Smith, Epidemic Intelligence Service Officer/Pharmacist Mycotic Diseases Branch, Centers for Disease Control & Prevention, United States
-Stacey L. Konkle, Epidemic Intelligence Service Officer/Epidemiologist Field Officer, Epidemiology Workforce Branch, Centers for Disease Control & Prevention, United States

This digital event will discuss how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.

Learning objectives:
1. Discuss the impact of COVID-19 pandemic on the prevalence and evolution of the seasonal influenza around the world.
2. Explore relevance and importance of the influenza vaccination in the coming seasons.
3. Discuss ways to effectively develop confidence in influenza vaccines among the public.
4. Share learnings to address complacency towards the influenza vaccination including harnessing the role of community pharmacists.

Moderator:
-Luís Lourenço, Professional Secretary FIP, Portugal

Panellists:
-Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
-Samantha Marsh, Research fellow University of Auckland, National Institute for Health Innovation, New Zealand
- Dermot Twomey, President Irish Pharmacy Union, Ireland
- Danielle Paes, Chief Pharmacist Officer Canadian Pharmacists’ Association, Canada

The COVID-19 pandemic has exacerbated the existing mental health crisis. People have reportedly been affected by worry, anxiety and fear due to the pandemic. This has placed a huge strain on health systems and their ability to deliver mental health care. Pharmacists are the most accessible healthcare providers and consistently rank among the most trusted health professionals. Hence, they can play an important role in the provision of mental health services to the public, thereby helping improve health outcomes and ameliorate the impact on health systems. This webinar explores the different services offered by pharmacists to improve mental health in an era of COVID-19 and beyond.

At the end of this webinar, participants will:
1. Recognize the role of pharmacists in addressing the mental health crisis.
2. Understand the needs of people living with mental health illness
3. Describe the various services offered by pharmacists to members of the public in the area of mental health.
4. Be familiar with the tools and resources available for pharmacists to improve the mental health of their patients.

Moderator:
-Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia

Panellists:
- Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
- David Odhiambo, Pharmacist, Kenya
- Andrea Murphy, Associate Professor, Dalhousie University, Canada
- David Gardner, Professor, Dalhousie University, Canada
- Helena Roennfeldt, Consumer Mentor, Griffith University, Australia

he COVID-19 pandemic has had detrimental effects on healthcare professionals and in diverse ways including physically, mentally, socially, and financially. The new and unique challenges directly associated with the COVID-19 pandemic are exacerbating an already stressful work environment for pharmacists too. Pharmacists are reporting high level of stress and burnout in practice. Hence, there is an urgent need for pharmacists to be equipped with the knowledge, tools, and resources to cope and thrive in crises. This webinar aims to provide perspectives from research and practice on the impact of workplace burnout on pharmacist mental health and highlight evidence-based supportive mechanisms and prevention tools to improve the mental health and wellbeing.  

Learning objectives:
Describe the impact of the COVID-19 pandemic on pharmacists’ wellbeing using case studies from different countries.
Discuss potential strategies to address burnout among pharmacists.
Describe the gaps in mental health education in pharmacy education.
Learn about the role of pharmacists in suicide prevention in the community.

Moderator:
-Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia

Panellists:
-Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
-Karlee Johnston, Associate Lecturer Pharmacology Australian National University, Australia
-Aiwen Wang, Principal Clinical Pharmacist, Lecturer Singapore General Hospital (SGH), Singapore. National University of Singapore (NUS), Singapore
-Lita Chew, Group Director (Allied Health) Singhealth, Singapore
-Hayley Gorton,Senior Lecturer in Pharmacy Practice University of Huddersfield, UK

Watch the recording the first day here. 

This event  explores FIP Development Goal’s role in pharmacy practice transformation globally.  It will identify practical strategies and WHO roles and challenges in vaccines transformational globally and how to help community pharmacists to improve their medication-related problems in community pharmacies.

Learning objectives:

1. To know the role of accreditation in education transformation 

2. Describe the educational transformational challenges in many countries in EMRO region such as KSA and Lebanon 

3. Describe approaches to establish inter-professional Education and practice 

4. Tele-pharmacy the new emerging opportunity to improve pharmacists role in patient care 

During this two days event we’ll explore transformation of pharmacy practice toward patient care during COVID-19 pandemic 

This event will also explore FIP Development Goal’s role in pharmacy practice transformation globally.  It will identify practical strategies and WHO roles and challenges in vaccines transformational globally and how to help community pharmacists to improve their medication-related problems in community pharmacies.

Learning objectives:

1. To know the role of accreditation in education transformation 

2. Describe the educational transformational challenges in many countries in EMRO region such as KSA and Lebanon 

3. Describe approaches to establish inter-professional Education and practice 

4. Tele-pharmacy the new emerging opportunity to improve pharmacists role in patient care 

More info here. 

This event aims to provide different perspectives on how the pandemic has impacted the scope of services provided by pharmacists in the community, hospital and clinical biology settings. In this roundtable discussion, a panel of experts in different areas will share their thoughts in which services were suspended or de-prioritised and need to be recovered or restored, and which new services emerged and may need to preserved beyond the pandemic.

Learning objectives:
1. Understand the impact of the pandemic on the scope of services pharmacists provide in the different settings
2. Discuss the priorities in the restoration or recuperation of services among different regions

Moderator:
- Robert Moss, President, Hospital Pharmacy Section, FIP - The Netherlands

Co - Moderators:
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden
- Julien Fonsart, President, FIP Clinical Biology Section, FIP - France

Panellist:
- Esteban Zavaleta, Director of Pharmacy, Hospital Clínica Bíblica - Costa Rica
- Ana Paula Martins, President, Portuguese Pharmaceutical Society - Portugal
- Ismael Olmos, Head of the Pharmacy Department, Member of the Clinical Pharmacology Unit, Hospital Vilardebó - Uruguay
- Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA) - South Africa
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP)
Hungary (home country) | Belgium (country in which EAHP is based in)
- Amrahi Buang, President, Malaysian Pharmacists Society (MPS) - Malaysia
- Chris Freeman, National President, Pharmaceutical Society of Australia - Australia
- Ziad Nassour, Former President of the Lebanese Order of Pharmacists, Lebanese Order of Pharmacists - Lebanon

As the global population continues to age, pharmacists' role in long term care and retirement homes will become increasingly more crucial. During the COVID-19 pandemic, with older persons being particularly vulnerable to the most severe forms of the disease, and often isolated from their families and loved ones, the care provided by long-term care facilities became all the more important to preserve health and well-being and prevent disease. This also raised the need to discuss the future role that pharmacists may play in supporting care and medication management in these facilities and to this particular population group.

1) Understanding the role that pharmacists play in medicine optimisation and reduction of medication-related harm in long-term care facilities
2) Understand the impact of the pandemic on the role of the pharmacists in long-term care
3) Discuss multidisciplinary synergies in the context of long-term care facilities
4) Identify changes in organisational culture of reducing psychotropic prescribing in long-term care facilities

Moderator:
-Robert Moss, President Hospital Pharmacy Section of the International Federation of Pharmacists, The Netherlands

Panellists:
- Tim Chen, President FIP Social and Administrative Pharmacy Section, Australia
- Anisa Shivji, Founder and CEO, RxVisit and Long term care expert, Canada
- Hui-Chen Su, Director Taiwan Society of Health-System Pharmacists (TSHP), China Taiwan
- Mouna Sawan, Researcher Centre for Medicine Use and Safety, Monash University Research Fellow, Australia

In this interactive session, faculty members and students, will share their past year’s experience with remote and online pharmacy education. Through pre- and in-session polling, we’ll share and discuss what we wish we knew one year ago, what we know now, and what we’d still like to know. Topics will be audience-driven, in the themes of educational methods, faculty support, student views, regional differences and others. The session's learnings will allow us to build future offerings, meeting members' needs.
Learning objectives:
At the end of this session, all participants (faculty members and students from all regions) will be able to:
- Participate in the sharing, assessment and discussion of global perspectives on remote and online learning, through pre- and in-session polling;
- Share and discuss their past year’s remote and online education and assessment experience, noting tips, challenges and rewards, and remaining questions;
- Provide innovative ideas to improve remote and online pharmacy education based on experience of the past year and goals for the future.

Moderators:
-Shaun Gleason, University of Colorado, USA
-Carl Schneider, University of Sydney, Australia
Panellists:
-Vivienne Mak, Monash University, Australia
-Sarah Scoular, University of Colorado Skaggs School of Pharmacy, USA
-Rebekah Moles, University of Sydney - Australia
-Claire Anderson, Division of Pharmacy Practice, UK
-Younes Karodeh, Howard University, USA
-Jamila Jorden, Howard University, USA
-Daniel Moraga, University of Valparaiso, Chile
-Emmanuella Nzeribe, Tamale Teaching Hospital, Ghana
-Priscilla Owusu-Mensah, Student, Kwame Nkrumah University, Ghana
-Ikwaibom Umoiyoho, Hospital Pharmacist, Nigeria
-LaMarcus Wingate, Howard University - USA
- Patricia Acuna, Faculty of Pharmacy. U. Valparaiso - Chile

During the COVID-19 pandemic the scientific community has united in the common strive to find the facts needed to fight the virus. Early in the pandemic there was a great push towards drug repurposing to find ways of treating those affected by the virus. Lately we have seen great advancements with vaccines helping to prevent the development of severe effects. In this webinar we will see two case studies: the repurposing of remdesivir and the development of an mRNA-based vaccine.

learning objectives:
In this webinar the participants will:
1. gain a better understanding of repurposing of remdesivir and the effectiveness of this treatment
2. learn about the development of mRNA vaccines utilized to prevent COVID
3. receive a greater understanding of how mRNA treatments can be applied to other diseases

Moderator:
Professor Ross McKinnon, Beat Cancer Professorial Chair in the College of Medicine and Public Health, Flinders University Australia

Panellists:
Dr. Rebecka Isaksson, Postdoctoral Research Associate, UCL Department of Chemistry, United Kingdom
PharmD Sunish Shah, Clinical Pharmacy Specialist (infectious diseases), University of Pittsburgh Medical Center,
Interim Clinical Coordinator (antimicrobial stewardship), Lawrence Memorial Hospital
Adjunct Professor, University of St. Joseph College of Pharmacy, US/India
Professor Colin Pouton, Professor of Pharmaceutical Biology, Monash University Australia

La farmacia humanitaria durante el covid-19. Gestión de desafíos durante una nueva era 

En este webinar discutiremos cómo diversas organizaciones humanitarias -FSF-Argentina, FSF-Chile y FSF-España- centradas en el trabajo de farmacia, se han adaptado a la pandemia de COVID-19.
Objetivos de aprendizaje:
1. Comprender cómo puede continuar el trabajo humanitario en tiempos de pandemia.
2. Conocer varios ejemplos de trabajo humanitario durante la pandemia de COVID-19.
3. Obtener nuevas ideas y construir redes dentro del campo de la farmacia humanitaria.
 
Los temas se basan en el  trabajo, incluyendo desafíos e innovaciones, que tres organizaciones (de España, Argentina y Chile) han desarrollado durante la pandemia de COVID-19

To see Part 1, click here. 

The world’s pharmacy team, including students and young pharmacists, is fighting COVID-19. Some students have been working on the frontline during COVID as volunteers. In this webcast, we will talk to pharmacists and students from different regions, learn about their experiences and share their stories.

Learning objectives:
1- Learn about pharmacy students’ and young pharmacists' experiences working in different countries during COVID-19 pandemic.
2- Discuss some of the challenges and possible solutions faced by pharmacy students and young pharmacists working during COVID-19.

Moderator:
Naoko Arakawa, Assistant Professor in International Pharmacy, University of Nottingham -UK
Co-moderator:
Dimitrios-Ilias Balourdas, PhD Candidate, Goethe University Frankfurt, Structural Genomics Consortium - Germany

Panellists:
- Sarah Emerson, Principal Advisor, Immunisation, Ministry of Health - New Zealand
- Gelan Mahmoud Zakhera, Registered Pharmacist at a Hospital Pharmacy International Pharmaceutical Student’s Federation - Egypt

Guests:
- Kats, Hospital pharmacist in training Haaglanden Medisch Centrum - The Netherlands

- Comfort Tanaka Gutu, Public Health Pharmacist (District Pharmacist), Ministry of Health and Childcare - Zimbabwe

COVID-19 has not only changed our daily routines, it also changed the traditional education system into distance learning or hybrid model. And convening classes with live and pre-recorded lessons challenged the pharmacy academics to innovate methods to engage their students in active online learning. This webinar will focus on pharmacy schools and accreditation bodies’ roles to make online learning creative and effective for students. Immersing pharmacy students in research, and meeting pharmacy students’ needs in an online environment will be addressed by the experts in their fields. Also, pharmacy students will discover enrichened ways to adjust and foster their education in online/virtual delivery.
Learning objectives:
1. To explore the roles of accreditation bodies in the quality of pharmacy programmes and transition to online
2. To determine the roles of schools of pharmacy in maintaining quality of programmes including skills development and experiential learning (especially when transitioning to online/virtual learning)
3. To describe the skills that professors/teachers must adopt/adapt to maintain quality of programmes (especially online/virtual versions)
4. To discuss how learners should adapt their learning to maintain their quality of learning during online/virtual delivery

Moderator:
- Carlo Marra, Dean School of Pharmacy University of Otago - New Zealand
Facilitator:
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham- UK
Panellists:
- Vibhu Solanki, Associate Professor of Community Pharmacy and Digital Education University of Nottingham - UK
- Janet P. Engle, Executive Director Accreditation Council for Pharmacy Education- USA
- Ilkay Erdogan Orhan, Dean Gazi University, Faculty of Pharmacy - Turkey
- Yahya Choonara, Professor University of Witwatersrand - South Africa

This session targets stakeholders involved in professional and continuing pharmacy education. Its purpose is to equip educators with strategies and techniques used in cultural sensitivity training for pharmacy students, an essential component of modern pharmacy education and optimal patient care. Specifically, experts will share strategies and lessons learned from creating and tailoring educational activities within the pharmacy curriculum that address cultural sensitivity.

Learning Objectives
At the end of this session, participants will be able to:
• Identify key steps in creating activities aimed to improve cultural sensitivity among pharmacy students
• Describe strategies educators can use to engage students in learning about and addressing the needs of patients from different culture
• Consider strategies for integrating cultural sensitivity training in pharmacy curricula

Moderator:
- Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain

Panellists:
- Mohamed Amin, Associate Professor, Beirut Arab University - Lebanon
- Cherie Lucas, Senior Lecturer and Clinical Education Manager (Experiential Placements), University of Technology - Australia
- Gizem Gülpınar, Research Assistant, Ankara University - Turkey

The Global COVID-19 impact on, consumer behavior/patient expectations, healthcare, and pharmacy workforce was noticeable.
The importance of pharmacy technicians in healthcare delivery pre-COVID-19, during crisis, and post-COVID-19 is crucial for the healthcare and patient services.
Pharmacy technicians from different work settings, community, hospital and pharmacy technicians’ association share their experiences with the public

Moderators:
Vijay Sarma, VP Pharmacy Marketing, McCann Health, Canada
Teri-Lynne Fogarty, Lecturer/ Coordinator of Pharmacy technician programme, Nelson Mandela University, South Africa

Speakers:
Isnarti Abu Aman, Pharmacy Technician Executive, Khoo Teck Puat Hospital, Singapore

Lorah Hickman, Senior Pharmacy Technician for Workforce and Development
Alfred Hospital, Australia

Birgitte Jeanette Andersen, Pharmaceutical consultant, Denmark

Mike Johnston, CEO, National Pharmacy Technician Association, USA

The world’s pharmacy team is fighting COVID-19 in a variety of ways. This webinar will host stakeholders working in various pharmacy sectors and from different geographical regions to share examples and draw on what we can learn in our pursuit of resilience. Research-driven findings will be shared that may aid in developing and advancing resilience within ourselves, for our patients, colleagues and the systems we are a part in our ability to tackle very challenging times. This event is delivered by FIP in collaboration with GRiT – Global Resilience Team, Led by: Dr Karen Whitfield.

The webinar aims to:
- Introduce participants to GRiT - Global Resilience Team ethos; a collaborative team passionate for raising awareness of the importance of developing resilience in our workforce.
- Showcase global perspectives from research and practice related to resilience in pharmacy.
- Share experiences in developing relevant and practical material to build into pharmacy curricula.

Moderator:
- Prof. Zubin Austin, Koffler Research Chair in Management, Leslie Dan Faculty of Pharmacy and Institute for Health Policy, Management, and Evaluation - Faculty of Medicine at the University of Toronto - Canada

Event Chair:
- Dr Catriona Bradley, Executive Director, The Irish Institute of Pharmacy - Ireland

Panellists:
- Dr Karen Whitfield, Associate Professor, School of Pharmacy, The University of Queensland - Australia
- Dr Sarah Wills, Senior Lecturer, The University of Manchester - UK
- Dr Dalia Bajis, Assistant Professor, Mohammed Al-Mana College for Medical Sciences - Saudi Arabia
- Dr Kyle Wilby, Associate Dean (Undergraduate) and Associate Professor, School of Pharmacy, University of Otago - New Zealand
- Dr Vibhuti Arya, Global Lead, Equity and Equality, International Pharmaceutical Federation (FIP) - USA
- Elizabeth Shekalaghe, Registrar /CEO, Pharmacy Council Tanzania - Tanzania
- Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - The Netherlands

Aim
To describe an evidence-based approach to self-care of mild COVID-19 symptoms

Learning Objectives:
• Describe approaches for preventing the spread of COVID-19
• List symptoms of COVID-19 – similarities and differences to influenza;
• Identify myths associated with self-care of COVID-19.
• Describe how mild symptoms such as fever and pain should be managed;
• Discuss when to refer more serious cases (escalating care in COVID-19).

Target audience – all those involved in the primary health care response to the coronavirus pandemic

Programme:
1. Welcome – Moderator Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation

2. COVID-19: preventing its spread and understanding its symptoms – Jaime Acosta-Gómez, Community Pharmacist and Pharmacy Owner, Spain

3. Dispelling myths about self-care treatments of COVID-19 – Christopher John, FIP Lead for Data and Intelligence

4. How to manage mild symptoms – self-care case study. Lars-Åke Söderlund, President FIP Community Pharmacy Section

5. Panel Discussion – questions and answers – All speakers

The COVID-19 pandemic has created an urgent need for diagnostic testing of patients and populations. In response, a multitude of COVID-19 tests are available to use from many different manufacturers and organisations. FIP has created a counselling information guide to assist practising pharmacists around the world in talking to patients who have questions concerning COVID-19 tests. This joint FIP-ASHP online event will present the newly developed guidance on Evaluation of Diagnostic Testing & Methods, as well as tools for pharmacists developed by the American Society of Health-System Pharmacists (ASHP). Panellists will discuss issues about care and how to manage the risks with evidence is the focus.

Moderator:
Zuzana Kusynova, Lead for Policy, Practice and Compliance, FIP, Netherlands

Panellist:
Mary Ann Kliethermes, Director, Medication Safety and Quality, American Society of Health-System Pharmacists (ASHP), USA

Catherine Duggan, CEO, FIP, Netherlands

Julien Fonsart, Senior specialist in laboratory medicine pharmacist, Hôpital Lariboisière, Université de Paris, France

Ally Dering-Anderson, Clinical Associate Professor in the Department of Pharmacy Practice & Science, University of Nebraska College of Pharmacy, USA

Margaret Underwood, Pharmacy student & FIP Intern, FIP, USA

Jasminka N Sarunac, Lead Pharmacist Investigational drugs/Clinical trial, Pharmacoepidemiologist, John Hunter Hospital, Australia

Se generó, durante esta pandemia, diversos tipos de evidencia respecto a los tratamientos para la Covid-19 pero aún así, el farmacéutico se enfrenta a la necesidad de tomar decisiones en ausencia de evidencia científica. Para apoyar la toma de decisiones, se compartirán los caminos emprendidos en el Hospital G. Marañón para la selección y protocolización del tratamiento para Covid-19 mostrando las herramientas utilizadas. La segunda parte será dedicada a los sistemas de farmacovigilancia (FV) sostenibles. La FV no es una actividad de lujo sino que es la base del uso seguro de medicamentos. Involucrar al paciente. Uso off-label de medicamentos.

1. Identificar los principales retos en la selección y protocolización de los tratamientos para Covid-19 en un contexto de falta de evidencia científica.
2. Analizar rol de las agencias reguladoras, la Comisión de Farmacia y Terapéutica del hospital, el grupo de expertos Covid-19 y grupo PROA del hospital y el farmacéutico en enfermedades infecciosas.
3. Compartir la experiencia en el abordaje de la selección y protocolización del tratamiento para Covid-19.
4. Discutir estrategias para organizar sistemas sostenibles para la gestión de riesgos de productos farmacéuticos y dispositivos médicos en la farmacia hospitalaria post-Covid.

Moderadora:
Nora Gerpe, Química Farmacéutica Asociación de Química y Farmacia del Uruguay-Uruguay

Panelistas:
Carmen Rodriguez, Farmacéutica Hospitalaria Hospital General Universitario Gregorio Marañón - España
Lucila Castro Pastrana, Full Professor Universidad de las Américas, Puebla - México

Tras la irrupción de la infección respiratoria por el nuevo coronavirus SARS-CoV-2, el desarrollo de vacunas capaces de proporcionar protección individual y poblacional frente a este virus se presenta como uno de los pilares fundamentales para controlar su expansión. Por otro lado, entre los numerosos efectos de la pandemia actual, conviene destacar los relacionados con la interrupción de los servicios básicos de salud, entre ellos, los programas de vacunación que están sufriendo importantes caídas y demoras en la mayoría de los países. En esta conferencia se abordarán las diferentes vacunas que se están en progreso para COVID-19, las tecnologías utilizadas y los adelantos en su desarrollo, así como la importancia de reestablecer y mantener los sistemas de inmunización.

Objetivos:
• Conocer las nuevas vacunas que están en desarrollado en el mundo para COVID-19.
• Describir el avance del proceso de desarrollo de las diferentes vacunas para COVID-19.
• Reconocer la importancia de la vacunación en el contexto de la pandemia.

Moderator: Nai-Hwa Mei
Panellists: Anasemon Aioub, Edurne Fdez. de Gamarra Martínez

Mike Scott and Nicola Goodfellow interview

The presentation is available here. Read the Covid-19 Special Collection by Pharmacy Education here. More on Pharmacy Education. 

The presentation is available here.

OBJETIVOS
• Conocer las áreas de impacto del COVID-19 en el sistema de salud.
• Describir los efectos del COVID-19 en la salud mental de los farmacéuticos y otros trabajadores de salud.
• Desarrollar un enfoque ampliado de los resultados generados por la pandemia que sirvan para el diseño de estrategias futuras de resiliencia.

The presentation is available here.

The presentation is available here.

The presentation is available here.

Presentation is available here.

Presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

Presentation is available here.

Presentation is available here

Presentation is available here